Thomas Carey, Ph.D.
Dr. Carey received his B.S. from Saint Lawrence University in Canton, N.Y. He earned his Ph.D. in Biochemical Pharmacology from State University of New York at Buffalo. After active duty for training in the Army Medical Service Corps, he completed a postdoctoral fellowship focusing on melanoma immunology and serology at Sloan-Kettering Institute with Lloyd Old. He joined the University of Michigan Medical School faculty focusing on developing research in head and neck cancer and rose through the ranks to Professor of Otolaryngology and Pharmacology. He is on the training faculty of the Cancer Biology Program, the Cell and Molecular Biology program, the Graduate Program in Pharmacology, The Translational Pathology Research program and the Advanced Training in Otolaryngology Research Program.
His current research interests are defining and understanding oral HPV infection and persistence as well as the molecular mechanisms of treatment resistance in head and neck cancer, particularly in HPV positive tumors and the effects of the cellular site of integration and alternate transcript expression on tumor behavior. Dr. Carey also studied mechanisms of autoimmune hearing loss, the development of new diagnostic assays for autoimmune hearing loss and understanding the role of the solute carrier protein SLC44A2 in the inner ear and its role in autoimmune disease and more recently its role in thrombosis and embolic disease.
Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, Worden FP, Wolf GT, Chepeha DB, Prince ME, Bradford CR, Mukherji SK, Eisbruch A, Carey TE. Nonendemic HPV-positive nasopharyngeal carcinoma: Association with poor prognosis. Int J Radiat Oncol Biol Phys 88:580-588, 2014. PMCID: PMC3989890
D’Souza G, Carey TE, William WN Jr, Nguyen ML, Ko EC, Riddell J 4th, Pai SI, Gupta V, Walline HM, Lee JJ, Wolf GT, Shin DM, Grandis JR, Ferris RL on behalf of the HNC SPORE HIV supplement consortium. Epidemiology of head and neck squamous cell cancer among HIV-infected patients. J Acquir Immune Defic Syndr 15:65(5):603-610, 2014. PMCID: PMC3999230
Dobrosotskaya IY, Bellile E, Spector ME, et al. Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx. Head Neck 36:617-23, 2014. PMCID:PMC4205960
Ojesina AI, Lichtenstein L, Freeman SS, et al. Landscape of genomic alterations in cervical carcinomas. Nature 506(7488):371-5, 2014. PMCID: PMC4161954
Owen JH, Hauff SJ, Tang AL, Graham MP, Czerwinski MJ, Kaddoura M, Papagerakis S, Bradford CR, Carey TE, Prince ME. UM-SCC-103: A Unique Tongue Cancer Cell Line That Recapitulates the Tumorigenic Stem Cell Population of the Primary Tumor. Ann Otol Rhinol Laryngol 123(9):662-672, 2014. PMCID: PMC4153472
Parfenov M, Pedamallu CS, Gehlenborg N, et al. Cancer Genome Atlas Network. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci USA 111(43):15544-15549, 2014. PMCID: PMC4217452
Spector ME, Chinn SB, Bellile E, et al. Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma. Head Neck 38:184–190, 2016. PMCID: PMC4370799
Vainshtein JM, McHugh JB, Spector ME, Walline HM, Komarck CM, Stenmark MH, Prince ME, Worden FP, Wolf GT, Bradford CR, Chepeha DB, Carey T, Eisbruch A. Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor. Head Neck 37(1):8-11, 2015. PMCID: PMC4153786
Chinn SB, Darr OA, Owen JH, Bellile E, McHugh JB, Spector ME, Papagerakis SM, Chepeha DB, Bradford CR, Carey TE, Prince MEP. Cancer stem cells: mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma. Head Neck 37(3):317-326, 2015. PMCID: PMC4127160
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517 (7536):576-582, 2015. PMCID:PMC4311405
Madera D, Vitale-Cross L, Martin D, Schneider A, et al. Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. Cancer Prev Res (Phila) 8(3):197-207, 2015. PMCID:PMC4355306 [Available on 2016-03-01]
Udager AM, Rolland DCM, McHugh JB, Betz BL, Murga-Zamalloa C, Carey TE, Marentette LJ, Hermsen MA, DuRoss KE, Lim MS, Elenitoba-Johnson KSJ, Brown NA. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res 75(13):2600-2606, 2015. PMCID: PMC4508878
Owen JH, Graham MP, Chinn SB, Darr OF, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Prince ME. Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines. Head Neck 2016 Apr;38 Suppl 1:E459-67. doi: 10.1002/hed.24019. Epub 2015 Jul 14. PMCID: PMC4530106 [Available on 2016-08-09]
Scheel A, Lin GC, McHugh JB, Komark CM, Walline HM, Prince ME, Zacharek MA, Carey TE. Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms. Int Forum Allergy Rhinol 5:701-707, 2015. PMCID: PMC4526407
Virani S, Bellile E, Bradford CR, Carey TE, Chepeha DB, Colacino JA, Helman JI, McHugh JB, Peterson LA, Sartor MA, Taylor JM, Walline HM, Wolf GT, Rozek LS. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. BMC Cancer 2015 Oct 30;15(1):825. doi: 10.1186/s12885-015-1806-8. PMCID: PMC4628358
Swiecicki PL, Zhao L, Belile E, Sacco AG, Chepeha DB, Dobrosotskaya I, Spector M, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey T, Worden FP. A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer. Invest New Drugs 33(6):1248-56, 2015. doi: 10.1007/s10637-015-0293-8. Epub 2015 Oct 10. PMID: 26453566
Brouwer AF, Eisenberg MC, Carey TE, Meza R. Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012. BMC Infect Dis 15:575, 2015. PMCID: PMC4648090
Sim MW, Grogan PT, Subrmanian C, Bradford CR, Carey TE, Forrest ML, Prince ME, Cohen MS. Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells. Laryngoscope 2015 Dec 21. DOI 10.1002/lary.25808 [EPub ahead of Print] PMID 26690734
Tillman BN, Yanik M, Birkeland AC, et al. Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing. Head Neck. 2016 Feb 5. doi: 10.1002/hed.24292. [Epub ahead of print] PMID: 26849095
Spector ME, Chinn SB, Bellile E, Gallagher KK, Kang SY, Moyer JS, Prince ME, Wolf GT, Bradford CR, McHugh JB, Carey TE, Worden FP, Eisbruch A, Ibrahim M, Chepeha DB. Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment. JAMA Otolaryngol Head Neck Surg. 2016 Feb 18. doi: 10.1001/jamaoto.2015.3602. [Epub ahead of print] PMID:26892642
Birkeland AC, Yanik M, Tillman BN, Scott MV, Foltin SK, Mann JE, Michmerhuizen NL, Ludwig ML, Sandelski MM, Komarck CM, Carey TE, Prince ME, Bradford CR, McHugh JB, Spector ME, Brenner JC. Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2016 Apr 14. doi: 10.1001/jamaoto.2016.0335. [Epub ahead of print] PMID: 27077364
Rudy SF, Brenner JC, Harris JL, Liu J, Che J, Scott MV, Owen JH, Komarck CM, Graham MP, Bellile EL, Bradford CR, Prince MEP, Carey TE. In vivo Wnt pathway inhibition f human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model. Otolaryngol Head Neck Surg (2016) 45:26 DOI 10.1186/s40463-016-0140-8.
Zhang Y, Koneva LA, Virani S, Arthur AE, Virani A, Hall PB, Warden CD, Carey TE, Chepeha DB, Prince ME, McHugh JB, Wolf GT, Rozek LS, Sartor MA. Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures. Clin Cancer Res. 2016 Apr 18. pii: clincanres.0323.2016. [Epub ahead of print] PMID: 27091409 [PubMed - as supplied by publisher]
Scheel A, Bellile E, McHugh JB, Walline HM, Prince ME, Urba S, Wolf GT, Eisbruch A, Worden F, Carey TE, Bradford C. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer. Laryngoscope 2016 Jun 27. doi: 10.1002/lary.25915. [Epub ahead of print] PMID: 27345657 [PubMed - as supplied by publisher]
Swiecicki PL, Bellile E, Sacco AG, et al. A phase II trial of AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck squamous cell carcinoma. Accepted, Invest New Drugs, May 2016.
Walline, HM, Komarck, CM, McHugh, JB, Bellile, EL, Brenner, JC, Prince, ME, McKean< EL, Chepeha, DB, Wolf, GT, Worden, FP, Bradford, CR., Carey, TE. High Risk Human Papillomavirus Integration into Cellular Gene or Intergenic Sites in Oropharyngeal Squamous Cell Carcinoma, Accepted Molecular Cancer Res July 2016
Misawa K, Kanazawa T, Misawa Y, Uehara T, Imai A, Takahashi G, Takebayashi S, Cole A, Carey TE, Mineta H. Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer. Transl Oncol 6:338-346, 2013. PMCID: PMC3660803
Walline HM, Komarck C, McHugh JB, Byrd SA, Spector ME, Hauff SJ, Graham MP, Bellile E, Moyer JS, Prince ME, Wolf GT, Chepeha DB, Worden FP, Stenmark MH, Eisbruch A, Bradford CR, Carey TE. High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and, oral cavity cancers: Comparison of multiple methods. JAMA Otolaryngol Head Neck Surg 139(12):1320-1327, 2013. PMCID:PMC4049419
Bradford CR, Kumar B, Bellile E, Lee J, Taylor J, D’Silva N, Cordell K, Kleer C, Kupfer R, Kumar P, Urba S, Worden F, Eisbruch A, Wolf GT, Teknos TN, Prince MEP, Chepeha DB, Hogikyan ND, Moyer JS, Carey TE. Biomarkers in advanced larynx cancer. Laryngoscope 124(1):179-87, 2014. PMCID: PMC4123871
Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, Worden FP, Wolf GT, Chepeha DB, Prince ME, Bradford CR,
Mukherji SK, Eisbruch A, Carey TE. Nonendemic HPV-positive nasopharyngeal carcinoma: Association with poor prognosis. Int J Radiat Oncol Biol Phys 88:580-588, 2014. PMCID: PMC3989890
Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, Kasibhatla S, SchullerAG, Li AG, Cheng D, Li J, Tompkins C, Pferdekamper AM, Steffy A, Cheng J, Kowal C, Phung V, Guo G, Wang Y, Graham MP, Brenner JC, Li C, Villarroel MC, Schultz PG, Wu X, McNamara P, Sellers WR, Petruzzelli L, Boral AL, Seidel HM, McLaughlin ME, Che J, Carey TE, Vanasse G, Flynn S, Harris JL. Targeting wnt-driven cancer through the inhibition of porcupine by LGK974. Proc Natl Acad Sci USA 110(50):20224-20229, 2013. PMCID: PMC3864356
D’Souza G, Carey TE, William WN Jr, Nguyen ML, Ko EC, Riddell J 4th, Pai SI, Gupta V, Walline HM, Lee JJ, Wolf GT, Shin DM, Grandis JR, Ferris RL on behalf of the HNC SPORE HIV supplement consortium. Epidemiology of HIV-Infected Head and Neck Squamous Cell Cancer Patients. J Acquir Immune Defic Syndr 15:65(5):603-610, 2014. PMCID: PMC3999230
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas, Nature. January 29, 2015;517 (7536):576-582. DOI: 10.1038/nature14129. PMCID:PMC4311405